Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]

Código QR

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]

Javier Zarranz-Ventura,1 Joshua O Mali2 1Institut Clínic d’Oftalmología (ICOF), Hospital Clinic, Barcelona, Spain; 2The Eye Associates, Sarasota, FL, USACorrespondence: Javier Zarranz-VenturaInstitut Clínic d’Oftalmología (ICOF), Hospit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zarranz-Ventura J, Mali JO
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	area under the curve best-corrected visual acuity diabetic macular edema corticosteroid fluocinolone acetonide implant dexamethasone implant Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/cb30bb0aa04343109604b98c82bcae47
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
por: Zarranz-Ventura J, et al.
Publicado: (2020)

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
por: Taylor K, et al.
Publicado: (2020)

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
por: Massin P, et al.
Publicado: (2016)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
por: Coelho J, et al.
Publicado: (2019)

Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
por: Kubaisi B, et al.
Publicado: (2018)

Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
por: Mushtaq B, et al.
Publicado: (2021)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
por: Adán A, et al.
Publicado: (2020)

Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE
por: Elbarky AM
Publicado: (2020)

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment
por: Steeples LR, et al.
Publicado: (2021)

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
por: Saedon H, et al.
Publicado: (2017)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
por: Udaondo P, et al.
Publicado: (2021)

Update on corticosteroids for diabetic macular edema
por: Schwartz SG, et al.
Publicado: (2016)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
por: Urbančič M, et al.
Publicado: (2019)

Central Pars Plana Vitrectomy + Phacoemulsification + Intraocular Lens Implantation in Patients with Small Eyes, Cataract, and Narrow Anterior Chambers
por: Silva Cayatopa F, et al.
Publicado: (2021)

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
por: Vadalà M, et al.
Publicado: (2020)

Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
por: Cham A, et al.
Publicado: (2016)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim M
Publicado: (2016)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
por: Zola M, et al.
Publicado: (2017)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
por: Wallsh J, et al.
Publicado: (2016)

Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
por: Chhablani J, et al.
Publicado: (2018)

25G lens resection combined with anterior vitrectomy in the treatment of congenital cataract
por: Fu-Rong Liao, et al.
Publicado: (2021)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
por: Wei W, et al.
Publicado: (2021)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
por: Kim MS, et al.
Publicado: (2021)

Anti-inflammatory drug-eluting implant model system to prevent wear particle-induced periprosthetic osteolysis
por: Rivera MC, et al.
Publicado: (2019)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017)

Dismal Survival in COVID-19 Patients Requiring ECMO as Rescue Therapy after Corticosteroid Failure
por: Sebastian Voicu, et al.
Publicado: (2021)

Is There a Difference in the Resonance Frequency Values Obtained Directly on the Implants and Abutments?
por: Pozzer,Leandro, et al.
Publicado: (2015)

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
por: Pacella E, et al.
Publicado: (2020)

Outcomes of Epiretinal Membrane Removal Utilizing Triamcinolone Acetonide Visualization and Internal Limiting Membrane Forceps
por: Asahi MG, et al.
Publicado: (2020)

Transdermal permeability of triamcinolone acetonide lipid nanoparticles
por: Qin ZM, et al.
Publicado: (2019)

Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization
por: Wallsh J, et al.
Publicado: (2021)

Actualización en Implantes Subperiósticos: Ranc-Implants Presentación de un Caso Clínico y Revisión de la Literatura
por: Rancaño-Álvarez,Emilio Adolfo, et al.
Publicado: (2019)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
por: Karttunen T, et al.
Publicado: (2019)

Clinical implant dentistry and related research
Publicado: (1999)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh J, et al.
Publicado: (2020)

Clinical oral implants research
Publicado: (1990)

Managing solar retinopathy with suprachoroidal triamcinolone acetonide injection in a young girl: a case report
por: Ameen Marashi, et al.
Publicado: (2021)

Cochlear implants international
Publicado: (2000)

Sordera y comunicacón : metodología verbotonal e implante coclear /
por: Gajic Liska, Karlo
Publicado: (2010)

The effect of bioadhesive in reduction of pain and healing time of Aphtha
por: M Motaleb Nejad, et al.
Publicado: (2003)